Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Relay Therapeutics Inc (NASDAQ: RLAY) closed at $2.72 in the last session, down -9.03% from day before closing price of $2.99. In other words, the price has decreased by -$9.03 from its previous closing price. On the day, 2.93 million shares were traded. RLAY stock price reached its highest trading level at $2.96 during the session, while it also had its lowest trading level at $2.69.
Ratios:
We take a closer look at RLAY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 15.95 and its Current Ratio is at 15.95. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 10, 2024, Upgraded its rating to Buy and sets its target price to $16 from $10.60 previously.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 27 ’25 when THOMAS J CATINAZZO bought 4,566 shares for $2.84 per share.
Patel Sanjiv sold 140,182 shares of RLAY for $539,701 on Feb 11 ’25. The President and CEO now owns 625,948 shares after completing the transaction at $3.85 per share. On Feb 13 ’25, another insider, Patel Sanjiv, who serves as the President and CEO of the company, sold 75,324 shares for $3.70 each. As a result, the insider received 278,699 and left with 883,089 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 461099840 and an Enterprise Value of -271721568. For the stock, the TTM Price-to-Sale (P/S) ratio is 46.06 while its Price-to-Book (P/B) ratio in mrq is 0.59. Its current Enterprise Value per Revenue stands at -27.153 whereas that against EBITDA is 0.715.
Stock Price History:
The Beta on a monthly basis for RLAY is 1.65, which has changed by -0.6608479 over the last 52 weeks, in comparison to a change of 0.06429911 over the same period for the S&P500. Over the past 52 weeks, RLAY has reached a high of $10.72, while it has fallen to a 52-week low of $2.83. The 50-Day Moving Average of the stock is -29.30%, while the 200-Day Moving Average is calculated to be -52.68%.
Shares Statistics:
According to the various share statistics, RLAY traded on average about 2.31M shares per day over the past 3-months and 2680480 shares per day over the past 10 days. A total of 167.76M shares are outstanding, with a floating share count of 127.70M. Insiders hold about 24.67% of the company’s shares, while institutions hold 80.05% stake in the company. Shares short for RLAY as of 1741910400 were 19121771 with a Short Ratio of 8.28, compared to 1739491200 on 15789969. Therefore, it implies a Short% of Shares Outstanding of 19121771 and a Short% of Float of 13.639999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
